The influence of cholesterol on mortality after transplantation is age dependent

Transplant International

Volumn 13, Issue SUPPL. 1, 2000, Pages

  Roodnat, J I ^a   Mulder, P G H ^b   Zietse, R ^a   Rischen Vos, J ^a   Van Riemsdijk, I C ^a   Ijzermans, J N M ^a   Weimar, W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Cholesterol; Mortality; Renal transplantation

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGE; ARTICLE; BLOOD; COMPARATIVE STUDY; FOLLOW UP; HISTOCOMPATIBILITY TEST; HUMAN; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MIDDLE AGED; MORTALITY; NETHERLANDS; PHYSIOLOGY; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME;

ADULT; AGE FACTORS; BIOLOGICAL MARKERS; CHOLESTEROL; FOLLOW-UP STUDIES; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MIDDLE AGED; NETHERLANDS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 18044385052     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2000.tb01998.x     Document Type: Article

References (12)

1. Anderson KM, Odell PM, Wilson PWF, Kannel WB (1990) Cardiovascular disease risk profiles. Am Heart J 121: 293-298
2. Ibels LS, Steward JH, Mahony JF, Shell AGF (1974) Deaths from occlusive arterial disease in renal allograft recipients. BMJ 3: 5523-2224
3. Kannel WB, Castelli WP, Gordon T, McNamara PM (1971) Serum cholesterol, lipoproteins, and the risk of coronary heart disease. Ann Intern Med 74: 1-12
4. Law MR, Wald NJ, Thompson SG (1994) By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischemic heart disease? BMJ 308: 367-373
5. LIPID Study Group (1998) Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339: 1349-1357
6. Nederlandse Hartstichting (1998) Treatment and prevention of coronary heart disease by changing the plasma cholesterol level (in Dutch). Consensus cholesterol, tweede herziening, April 1998
7. Raine AEG, Margreiter R, Brunner FP, Ehrich JHH, Geerlings W, Landais P, Loirat C, Mallick NP, Selwood NH, Tufveson G, Valderrabano F (1991) Report on management of renal failure in Europe, XXII, 1991. NDT 7 [Suppl 2]:7-35
8. Roodnat JI, Zietse R, Mulder PGH, Rischen-Vos J, Gelder van T, Ijzermans JNM, Weimar W (1999) The vanishing importance of age in renal transplantation. Transplantation 67: 567-580
9. Sacks FM, Pfeffer MA, Moye MA, Rouleau JL, Rutherford JD, et al (1996) The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels.N Engl J Med 335: 1001-1009
10. Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389
11. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, et al (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333: 1301-1307
12. Wheeler DC (1996) Cardiovascular disease in patients with chronic renal failure. Lancet 348: 1673-1674